锦华新材：芯片清洗剂产品顺利交付，精细化工龙头开启发展新篇章-20260310

Investment Rating - The investment rating for the company is "Outperform" (Maintain) [1][3] Core Views - The company reported a revenue of 1.032 billion yuan for 2025, a year-on-year decrease of 16.72%, and a net profit attributable to the parent company of 195 million yuan, down 7.68% year-on-year. The earnings forecast for 2025 has been revised down, while the forecasts for 2026 and 2027 remain unchanged, with expected net profits of 269 million yuan and 350 million yuan respectively. The current stock price corresponds to P/E ratios of 31.2, 22.6, and 17.3 for 2025, 2026, and 2027 respectively. The company is optimistic about the recovery in the downstream organic silicon and pesticide industries, as well as the delivery of electronic-grade hydroxylamine salt water solution products, hence maintaining the "Outperform" rating [3][4]. Company Overview - The company is a leading enterprise in the domestic silane crosslinking agent and hydroxylamine salt segment, focusing on the research, production, and sales of ketoxime series fine chemicals. Its main products include silane crosslinking agents, hydroxylamine salts, methoxyamine hydrochloride, and acetaldehyde oxime, which are widely used in construction materials, energy, electronics, new energy vehicles, and metal beneficiation [4][5]. Product Development - By the end of 2025, the company successfully delivered electronic-grade hydroxylamine water solution orders to end-chip customers. This high-end product is used as a cleaning agent in aluminum processing for chip manufacturing. The company has developed a safe and green preparation process for hydroxylamine, breaking the technical monopoly in the industry. The quality of its electronic-grade hydroxylamine water solution is comparable to that of BASF's products and has been validated by several chip manufacturing and cleaning agent compounding companies [5]. Financial Summary and Valuation Indicators - The financial summary indicates that the company's revenue is projected to recover to 1.339 billion yuan in 2026, with a year-on-year growth of 29.7%. The net profit is expected to increase to 269 million yuan in 2026, reflecting a growth rate of 37.9%. The gross margin is anticipated to improve from 29.6% in 2025 to 30.8% in 2026, while the net margin is expected to rise from 18.9% to 20.1% in the same period. The EPS is projected to be 1.98 yuan in 2026, with a P/E ratio of 22.6 [7][10].